Patent ID: 9056837
Filing Date: 2015-06-16
Classification: A61K,A61P,C07D

Abstract:
1. A method for the treatment of a disease or disorder, wherein the disease or disorder is characterized as a neurodegenerative disease characterized by the accumulation of abnormal protein aggregates in the brain, or a hyperproliferative disease of the brain or central nervous system, comprising administering to a subject a pharmaceutically effective amount of a compound according formula (I): wherein: A R R or R Y is —NHCO—, —CONH—, —NHSO D is a 5 or 6 member aryl, hetaryl or hetcyclic ring having at least one N, S, or O ring atom, or a C ring atom forming an oxo (C═O) moiety; provided that D is not a substituted phenyl group if A R in a free or pharmaceutically acceptable salt form, to a patient in need thereof.